| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Katherine A. High | Q41502889 |
| P921 | main subject | hemophilia | Q134003 |
| P304 | page(s) | 375-381 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Hematology / the Education Program of the American Society of Hematology | Q26842068 |
| P1476 | title | The gene therapy journey for hemophilia: are we there yet? | |
| P478 | volume | 2012 |
| Q38236204 | AAV-mediated gene therapy for atherosclerosis |
| Q54958581 | Emerging therapies for hemophilia: controversies and unanswered questions. |
| Q37075305 | Evaluation of the biological differences of canine and human factor VIII in gene delivery: implications in human hemophilia treatment |
| Q27009261 | Gene therapy of inherited retinal degenerations: prospects and challenges |
| Q35671749 | Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo |
| Q36835166 | Issues in pediatric haemophilia care |
| Q45873013 | Novel approaches to hemophilia therapy: successes and challenges. |
| Q38529941 | Obstacles and future of gene therapy for hemophilia |
| Q37690441 | Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice |
| Q61811175 | Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy |
| Q33902499 | The potential of adeno-associated viral vectors for gene delivery to muscle tissue |
| Q95271852 | Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A |
Search more.